skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All


Show More


Show More


Show More

Show More

67 Total results for product and free and sample content found


Scrip Asia 100 Report Extract

26 Mar 2021


Access Asia Pharma Intelligence expertise and hear from Pharma journalists across Asia to reveal deep regional expertise with this sample of Scrip's Asia 100 Report.

Topic Business Strategies China Company Analysis Drug Development Landscape Market Intelligence


Coronavirus Update: Will Dexamethasone Breakthrough Make Remdesivir Irrelevant?

27 Nov 2020

Coronavirus Update: Will Dexamethasone Breakthrough Make Remdesivir Irrelevant?

The RECOVERY trial has produced clear results for the cheap steroid treatment dexamethasone. What does it mean for Gilead's antiviral remdesivir?

Topic Coronavirus Clinical Trials Company Analysis


After Vaccines Row, Sanofi Invests In France, Macron To Secure Supplies

27 Nov 2020

After Vaccines Row, Sanofi Invests In France, Macron To Secure Supplies

Sanofi’s €610m investment helps row to be forgotten – though Macron will ‘place bets’ on several COVID-19 vaccines, not just France’s homegrown candidate.

Topic Coronavirus Company Analysis


Scrip Asia 100: Sponsorship Opportunities

16 Jul 2020

MS Scrip Asia 100 Sample Chapter Cover Image

The annual “Scrip Asia 100”, the highly anticipated financial performance ranking of pharma companies headquartered in the APAC region, is coming soon. Don’t miss your opportunity to position yourself as a leader in APAC pharma with a sponsorship in this indispensable publication.  

Topic Company Analysis Market Intelligence Outlook


Titans of Pharma 2020: A Bumper Year For Top Executive Compensation

06 Jul 2020

Titans of Pharma

CEO pay at the top 15 pharma companies increased by 3.9% in 2019. But how did that match up to company performance? Read the article now available from Scrip and learn who were the big winners, and how their companies performed financially.

Topic Leadership Company Analysis Market Access

Medtech Insight

Medtech Insight Company Review

20 Apr 2020

Medtech Insight Company Review

Now more than ever, staying on top of the shifting dynamics of the medtech market is critical. Medtech Insight takes you inside recent company results for your view into the health and market landscape of medtech as we enter an unprecedented era.

Topic Cardiovascular Company Analysis


Moderna Inovio Coronavirus Vaccine Candidates Fast-Tracked By International Coalition

By Andrew McConaghie 30 Jan 2020


The Coalition for Epidemic Preparedness Innovations adds new deal with mRNA specialist Moderna for rapid development of coronavirus vaccine.

Topic Company Analysis Coronavirus Infectious Diseases Vaccines


More Top Level Pharma Exits In India As Cipla COO Departs

06 Dec 2019


Cipla’s global chief operating officer is leaving the company to pursue new interests, amid a spate of top-level exits that have marked the pharma sector in India in 2019.

Topic Leadership Company Analysis

HBW Insight

Novartis Wins Second Landmark German Case, This Time For Probiotics

By David Ridley 13 Nov 2019


Following a landmark win against the German government for the Rx-to-OTC switch of desloratadine last month, Novartis has again secured a victory in the German Higher Court system, this time to continue marketing its Biosan probiotics range in the country.

Topic Company Analysis Policy & Regulation

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: